Showing results (141-150 of 356) with videos related to
Sort By:
Pageof 36
European Journal of Pharmacology|February 5, 1982
Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468)J M Van Nueten, P A Janssen, A De Ridder, et al.Psychopharmacology|January 1, 1987
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitorA Wauquier, H Van Belle, W A Van den Broeck, et al.Electroencephalography and Clinical Neurophysiology|January 1, 1979
Visual and computer-based analysis of 24 h sleep-waking patterns in the dogA Wauquier, J L Verheyen, W A van den Broeck, et al.Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1982
Prevention of physostigmine-induced lethality in rats. A pharmacological analysisC J Niemegeers, F Awouters, F M Lenaerts, et al.Stroke|October 1, 1989
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in ratsM De Ryck, J Van Reempts, M Borgers, et al.Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1978
Protection of rats from compound 48/80-induced lethality. A simple test for inhibitors of mast cell-mediated shockC J Niemegeers, F Awouters, van Nueten, et al.Experientia|May 15, 1979
Ketoconazole -- a new broad spectrum orally active antimycoticD Thienpont, J Van Cutsem, F Van Gerven, et al.Arzneimittel-Forschung|January 1, 1976
Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogsC J Niemegeers, K H Schellekens, W F Van Bever, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1990
Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the ratF De Clerck, L Van Gorp, J Beetens, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compoundsD de Cheffoy de Courcelles, K de Loore, E Freyne, et al.Pageof 36